A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
CIIS
English
Next cohort: Jun 1, 2026
150 hours
Start date: June 1, 2026
Application deadline: June 1, 2026
The Certificate in Psychedelic-Assisted Therapies and Research is a 12-month program housed in the CIIS Center for Psychedelic Therapies and Research. It offers hybrid or online study for clinicians, therapists, researchers, clergy, and professionals in related fields seeking training in responsible psychedelic-assisted therapy. The curriculum covers contemporary research, safety and legal compliance, psychotherapy competencies, cultural and traditional wisdom practices, and personal and experiential learning. Source text indicates emphasis on MDMA and psilocybin, with additional coursework on ketamine-assisted psychotherapy. Training is described as grounded in compassion, integrity, inclusion, and the CIIS Beloved Community Agreements. The program does not require or promote the use of illegal substances and is conducted in compliance with federal and state regulations.
Clinicians, therapists, researchers, clergy, and professionals in related or affiliated fields seeking training in psychedelic-assisted therapy and research.
The California Institute of Integral Studies (CIIS) launched the world's first university-affiliated Psychedelic-Assisted Therapies and Research Certificate Program in 2015, establishing the gold standard for post-graduate psychedelic clinician training, with cohorts now also offered a B.S. in Psychedelic Studies and a KAP clinic. Based in San Francisco, CIIS is a non-profit graduate university pioneering integral approaches to consciousness, therapy, and psychedelic medicine.
By Ketamine Academy
Spravato FastTrack is an implementation course for clinics that want to add Spravato (esketamine) services. It covers REMS certification, procurement, prior authorization, billing, documentation, and related operational steps.
By Double Blind
This article examines how ketamine clinics may serve as a model for future legal psychedelic therapy, especially for MDMA and psilocybin. It compares clinic models, regulation, and the role of psychotherapy in treatment delivery.
By Phoenix Academy
Online course in clinical psychedelic therapy covering preparation, dosing, safety, integration, and work with co-therapists and clients. Includes videos, interactive content, quizzes, and course documents.